Volastra Therapeutics logo

Volastra Therapeutics

New York, NY

Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers by exploiting unique insights into chromosomal instability.

volastratx.com

Company Details

Founded

2019

Employees

Between 20 - 100 employees

Raised

$119,000,000

Headquarters Location

New York, NY

Public

No

Acquired

No

CEO

David SouthwellDavid Southwell

Company Collections

These are collections Volastra Therapeutics is a part of. Click on the collection name to view similar companies.

Volastra Therapeutics' Industries

Volastra Therapeutics' Tech Stack

Current Job Listings

Listing 0 of 3 job openings

    Volastra Therapeutics Headquarters Location

    1361 Amsterdam Ave suite 520, New York, NY 10027

    Total Amount Raised: $119,000,000

    Volastra Therapeutics Funding Rounds

    • Series Unknown

      $15,000,000

    • Series A

      $60,000,000

      Series A Investors

      Arch Venture Partners
      Eli Lilly and Company
      Polaris Partners
      Meyer Ventures
      Vida Ventures
      Catalio Capital Management
      Droia Ventures
      Cornell University

    • Seed

      $32,000,000

      Seed Investors

      Catalio Capital Management
      Vida Ventures
      Arch Venture Partners
      Quark Venture
      Droia Ventures
      Polaris Partners

    • Seed

      $12,000,000

      Seed Investors

      Polaris Partners
      Droia Ventures
      GF Securities
      Arch Venture Partners
      Quark Venture
      Global Health Sciences Venture Fund
    Funding info provided by Diffbot.

    Volastra Therapeutics Reviews

    0 out of 5 stars

    Based on 0 reviews

    Review data

    Share your thoughts

    Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Volastra Therapeutics.

    Recent reviews